Gavin Wood, Chief Financial Officer at Adaptimmune Therapeutics PLC (ADAP), bought 39,000 shares at $0.29 ($11K) on 2022-05-20, disclosed to the SEC on 2022-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ADAP | BUY | 2020-06-30 | $53K | — | Filing → |
| AFFX | SELL | 2015-02-18 | $15K | — | Filing → |
| AFFX | SELL | 2015-01-21 | $265K | — | Filing → |